Riskpilot← Back to searchSign inGet full accessDrugstars ApS
APSBankruptCVR 36893974Emdrupvej 28A, 4.Other software publishing · NACE 5829Est. 20156 employees
Revenue 2020
DKK 1,6M
+54% vs 2019
EBITDA margin
-461.2%
+17% vs 2019
Equity ratio
-6.8%
Financial strength
Net profit 2020
DKK -7M
+17% vs 2019
| Revenue | DKK 1,6M | +54% |
| EBITDA | DKK -7,5M | +17% |
| Net profit | DKK -7M | +17% |
| Total assets | DKK 5,2M | -42% |
| Equity | DKK -359K | -105% |
| Employees | 6 | — |
Legal name
Drugstars ApS
CVR number
36893974
Legal form
Anpartsselskab
NACE code
5829 · Other software publishing
Founded
13. maj 2015
Share capital
DKK 196.737
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af selskabets administrerende direktør og bestyrelsesformanden i forening eller af den samlede bestyrelse.
Address
Emdrupvej 28A, 4.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | -963 | -1.940 | -2.226 | 1.061 | 1.634 |
| Staff expenses | -228 | -1.804 | -2.455 | -4.670 | -5.465 |
| EBITDA | -1.191 | -3.744 | -4.680 | -9.067 | -7.534 |
| Depreciation & amort. | -0 | -0 | -0 | -20 | -30 |
| EBIT | -1.191 | -3.744 | -4.680 | -9.086 | -7.564 |
| Net financials | -0 | -2 | 2 | -77 | -166 |
| Profit before tax | -1.191 | -3.746 | -4.678 | -9.163 | -7.730 |
| Tax | -247 | -443 | -679 | -833 | -780 |
| Net profit | -944 | -3.302 | -3.999 | -8.330 | -6.950 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 1.490 | 3.203 | 1.346 | 8.980 | 5.246 |
| Equity | 1.282 | 2.875 | 374 | 6.591 | -359 |
| Long-term debt | 16 | 15 | 0 | 0 | 2.479 |
| Short-term debt | 192 | 312 | 972 | 2.388 | 3.126 |
| Total debt | 208 | 328 | 972 | 2.388 | 5.605 |
EBITDA margin
-461.2%
This company
15.8%
Market median
-3019% vs market
20162020
Equity ratio
-6.8%
This company
38.2%
Market median
-118% vs market
20162020
Return on equity
-695040100.0%
This company
18.4%
Market median
-3777391948% vs market
20162020
Net profit margin
-425.5%
This company
8.1%
Market median
-5353% vs market
20162020
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20162020
Debt / equity
15.62×
This company
0.62×
Market median
-2419% vs market
20162020
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
CM Chief Executive Officer | Chief Executive Officer | 2016 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (11) | ||
| Chairman | 2020 – 2021 | |
| Chairman | 2018 – 2020 | |
| Board of Directors | 2019 – 2021 | |
| Board of Directors | 2016 – 2017 | |
| Board of Directors | 2019 – 2021 | |
| Board of Directors | 2017 – 2018 | |
| Board of Directors | 2019 – 2021 | |
| Board of Directors | 2019 – 2021 | |
| Chairman | 2016 – 2018 | |
| Board of Directors | 2017 – 2021 | |
| Board of Directors | 2017 – 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 10–14.99% | 10–14.99% | 2019 | |
| Individual | 5–9.99% | 5–9.99% | 2019 | |
| Company | 5–9.99% | 5–9.99% | 2017 | |
| Company | 10–14.99% | 10–14.99% | 2019 | |
| Company | 5–9.99% | 5–9.99% | 2019 | |
| Company | 10–14.99% | 10–14.99% | 2017 | |
| Company | 25–33.32% | 25–33.32% | 2019 | |
| Individual | 10–14.99% | 10–14.99% | 2019 | |
| Company | 5–9.99% | 5–9.99% | 2016 | |
| Company | 5–9.99% | 5–9.99% | 2017 | |
| Company | 5–9.99% | 5–9.99% | 2019 | |
| Company | 5–9.99% | 5–9.99% | 2017 | |
| Company | 5–9.99% | 10–14.99% | 2019 | |
| Company | 5–9.99% | 5–9.99% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Drugstars ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claus Møldrup | Chief Executive Officer | 0 companies |
| Henrik Holmark | Chairman | 0 companies |
| Henrik Holmark | Chairman | 0 companies |
| Ekaterina Gianelli | Board of Directors | 0 companies |
| Peter Mühlendorph Egehoved | Board of Directors | 0 companies |
| Eric Lagier | Board of Directors | 0 companies |
| Sanne Lyng Marsland | Board of Directors | 0 companies |
| Christian Hjortgaard | Board of Directors | 0 companies |
| Ulli Jendrik Koop | Board of Directors | 0 companies |
| Jesper Kilbæk | Chairman | 0 companies |
| Anders Kjær | Board of Directors | 0 companies |
| Caroline Erup Widriksen | Board of Directors | 0 companies |